Caladrius Biosciences, Inc. (NASDAQ: CLBS), a cell therapy company combining an industry-leading development and manufacturing services provider through its subsidiary ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE